| Role |
Name |
Disclosure |
Details |
| Author | J Ivan Lopez, MD, FAAN, Associate Professor of Neurology, Residency Training Program Director, Department of Neurology, University of South Alabama | Nothing to disclose | Details | | Coauthor | John F Rothrock, MD, Vice Chair and Professor of Neurology, University of Alabama at Birmingham; Adjunct Professor of Public Health, University of Montana | Pozen Merck GlaxoSmithKline OrthoMcNeil Minster Pfizer | Details | | Medical Editor | Raj D Sheth, MD, Professor, Departments of Neurology and Pediatrics, Director of Comprehensive Epilepsy Program, Department of Neurology, University of Wisconsin at Madison | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Kenneth J Mack, MD, PhD, Senior Associate Consultant, Department of Child and Adolescent Neurology, Mayo Clinic | Nothing to disclose | Details | | CME Editor | Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital | Nothing to disclose | Details | | Chief Editor | Amy Kao, MD, Assistant Professor, Department of Neurology, Department of Pediatrics, Division of Pediatrics, Oregon Health and Science University; Consulting Staff, Shriners Hospital | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Kenneth J Mack, Managing Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Matthew J Baker, CME Editor |
The contributor discloses no conflict of interest. |
|